Pegylated Filgrastim
Showing 1 - 25 of 927
Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)
Recruiting
- Retinoblastoma
- vincristine
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 25, 2022
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)
Not yet recruiting
- Lymphoma
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Apr 18, 2023
Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)
Not yet recruiting
- Angiosarcoma
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2023
Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)
Completed
- Childhood Solid Tumors
- Talazoparib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 8, 2021
Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)
Completed
- Leukemia
- Acute Lymphoblastic Leukemia
- Rituximab
- +11 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 1, 2020
Quality and Quantity of M-PRP Cellular Content Filgrastim vs.
Recruiting
- Healthy
-
Gulf Breeze, FloridaAndrews Research and Education Foundation
Oct 6, 2022
Lymphoma Trial in Houston (Cyclophosphamide, Mesna, Vincristine)
Completed
- Lymphoma
- Cyclophosphamide
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 2, 2020
Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)
Completed
- Acute Myeloid Leukemia
- +2 more
- Fludarabine
- +3 more
-
Milano, Lombardia, ItalyOspedale San Raffaele
Jul 18, 2022
Germ Cell Tumor Trial in Australia, New Zealand, United States (Bleomycin (active name: Bleomycin Sulfate), Etoposide,
Recruiting
- Germ Cell Tumor
- Bleomycin (active name: Bleomycin Sulfate)
- +4 more
-
New York, New York
- +27 more
Nov 25, 2021
Early-stage Breast Cancer Trial in Ottawa (Filgrastim, Pegfilgrastim)
Recruiting
- Early-stage Breast Cancer
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Jun 10, 2021
Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, Unresectable Biliary Tract Carcinoma Trial (Tripegfilgrastim)
Not yet recruiting
- Unresectable Pancreatic Cancer
- +2 more
- (no location specified)
Nov 13, 2023
Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Worldwide (drug, biological, radiation)
Recruiting
- Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Cyclophosphamide
- +12 more
-
Birmingham, Alabama
- +187 more
Jan 31, 2023
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)
Completed
- Non-Hodgkin's Lymphoma
- Plasma Cell Myeloma
- Hematopoietic Cell Transplantation
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
ST Elevation Myocardial Infarction Trial (Dutogliptin + Filgrastim, Placebo)
Not yet recruiting
- ST Elevation Myocardial Infarction
- Dutogliptin + Filgrastim
- Placebo
- (no location specified)
Jun 1, 2023
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Obesity, PreDiabetes Trial in Saint Louis (ADI-PEG20, Placebo)
Not yet recruiting
- Obesity
- PreDiabetes
- ADI-PEG20
- Placebo
-
Saint Louis, MissouriWashington University School of Medicine
Apr 24, 2023
Advanced Ovarian Cancer Trial in Spain (Olaparib, Pegylated Liposomal Doxorubicin)
Completed
- Advanced Ovarian Cancer
- Olaparib
- Pegylated Liposomal Doxorubicin
-
Sabadell, Barcelona, Spain
- +7 more
Jan 25, 2023
Platinum-resistant Ovarian Cancer
Not yet recruiting
- Ovarian Cancer
- pegylated liposomal doxorubicin
- (no location specified)
Aug 2, 2023
Multiple Myeloma and Malignant Lymphoma Trial in Japan (KRN125(pegfilgrastim), PLR001(plerixafor), KRN8601(filgrastim),
Recruiting
- Multiple Myeloma and Malignant Lymphoma
- KRN125(pegfilgrastim), PLR001(plerixafor)
- KRN8601(filgrastim), PLR001(plerixafor)
-
Nagoya, Aichi, Japan
- +20 more
May 20, 2022